Your browser doesn't support javascript.
loading
AGAPP: efficacy of first-line cisplatin, 5-fluorouracil with afatinib in inoperable gastric and gastroesophageal junction carcinomas. A Hellenic Cooperative Oncology Group study.
Zarkavelis, George; Samantas, Epaminontas; Koliou, Georgia-Angeliki; Papadopoulou, Kyriaki; Mauri, Davide; Aravantinos, Gerasimos; Batistatou, Anna; Pazarli, Elissavet; Tryfonopoulos, Dimitrios; Tsipoura, Anna; Bobos, Mattheos; Psyrri, Amanda; Makatsoris, Thomas; Petraki, Constantina; Pectasides, Dimitrios; Fountzilas, George; Pentheroudakis, George.
Afiliação
  • Zarkavelis G; Department of Medical Oncology, University of Ioannina, Ioannina, Greece.
  • Samantas E; Society for Study of Clonal Heterogeneity of Neoplasia (EMEKEN), Ioannina, Greece.
  • Koliou GA; Third Department of Medical Oncology, Agii Anargiri Cancer Hospital, Athens, Greece.
  • Papadopoulou K; Section of Biostatistics, Hellenic Cooperative Oncology Group, Data Office, Athens, Greece.
  • Mauri D; Laboratory of Molecular Oncology, Hellenic Foundation for Cancer Research, Aristotle University of Thessaloniki, Thessaloniki, Greece.
  • Aravantinos G; Department of Medical Oncology, University of Ioannina, Ioannina, Greece.
  • Batistatou A; Society for Study of Clonal Heterogeneity of Neoplasia (EMEKEN), Ioannina, Greece.
  • Pazarli E; Second Department of Medical Oncology, Agii Anargiri Cancer Hospital, Athens, Greece.
  • Tryfonopoulos D; Department of Pathology, Ioannina University Hospital, Ioannina, Greece.
  • Tsipoura A; Department of Pathology, Papageorgiou Hospital, Aristotle University of Thessaloniki, School of Health Sciences, Faculty of Medicine, Thessaloniki, Greece.
  • Bobos M; Second Department of Internal Medicine, Agios Savvas Cancer Hospital, Athens, Greece.
  • Psyrri A; Department of Pathology, Agii Anargiri Cancer Hospital, Athens, Greece.
  • Makatsoris T; Laboratory of Molecular Oncology, Hellenic Foundation for Cancer Research, Aristotle University of Thessaloniki, Thessaloniki, Greece.
  • Petraki C; Section of Medical Oncology, Department of Internal Medicine, Attikon University Hospital, Faculty of Medicine, National and Kapodistrian University of Athens School of Medicine, Athens, Greece.
  • Pectasides D; Division of Oncology, Department of Medicine, University Hospital, University of Patras Medical School, Patras, Greece.
  • Fountzilas G; Department of Pathology, Metropolitan Hospital, Piraeus, Greece.
  • Pentheroudakis G; Oncology Section, Second Department of Internal Medicine, Hippokration Hospital, Athens, Greece.
Acta Oncol ; 60(6): 785-793, 2021 Jun.
Article em En | MEDLINE | ID: mdl-34003074
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Adenocarcinoma / Cisplatino Tipo de estudo: Guideline Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Adenocarcinoma / Cisplatino Tipo de estudo: Guideline Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article